Global Widely-targeted Metabolomics Supply, Demand and Key Producers, 2026-2032
The global Widely-targeted Metabolomics market size is expected to reach $ 531 million by 2032, rising at a market growth of 9.9% CAGR during the forecast period (2026-2032).
Widely targeted metabolome is a metabolome detection technology that integrates the advantages of non-targeted and targeted metabolite detection technologies.The widely targeted metabolome can compare the types and abundance differences of metabolites between different samples, screen out significant differences in metabolites with important biological significance between different groups, and qualitatively and quantitatively detect low-abundance trace-level compounds.
This report studies the global Widely-targeted Metabolomics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Widely-targeted Metabolomics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Widely-targeted Metabolomics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Widely-targeted Metabolomics total market, 2021-2032, (USD Million)
Global Widely-targeted Metabolomics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Widely-targeted Metabolomics total market, key domestic companies, and share, (USD Million)
Global Widely-targeted Metabolomics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Widely-targeted Metabolomics total market by Type, CAGR, 2021-2032, (USD Million)
Global Widely-targeted Metabolomics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Widely-targeted Metabolomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Proteomics, Lifeasible, BGI Genomics, Metware Biotechnology Inc (Metware), TianGen, Gene Denovo, SHANGHAI OE Biotech, ShangHai Biotree, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Widely-targeted Metabolomics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Widely-targeted Metabolomics Market, By Region:
1. How big is the global Widely-targeted Metabolomics market?
2. What is the demand of the global Widely-targeted Metabolomics market?
3. What is the year over year growth of the global Widely-targeted Metabolomics market?
4. What is the total value of the global Widely-targeted Metabolomics market?
5. Who are the Major Players in the global Widely-targeted Metabolomics market?
6. What are the growth factors driving the market demand?
Widely targeted metabolome is a metabolome detection technology that integrates the advantages of non-targeted and targeted metabolite detection technologies.The widely targeted metabolome can compare the types and abundance differences of metabolites between different samples, screen out significant differences in metabolites with important biological significance between different groups, and qualitatively and quantitatively detect low-abundance trace-level compounds.
This report studies the global Widely-targeted Metabolomics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Widely-targeted Metabolomics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Widely-targeted Metabolomics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Widely-targeted Metabolomics total market, 2021-2032, (USD Million)
Global Widely-targeted Metabolomics total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Widely-targeted Metabolomics total market, key domestic companies, and share, (USD Million)
Global Widely-targeted Metabolomics revenue by player, revenue and market share 2021-2026, (USD Million)
Global Widely-targeted Metabolomics total market by Type, CAGR, 2021-2032, (USD Million)
Global Widely-targeted Metabolomics total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Widely-targeted Metabolomics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Proteomics, Lifeasible, BGI Genomics, Metware Biotechnology Inc (Metware), TianGen, Gene Denovo, SHANGHAI OE Biotech, ShangHai Biotree, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Widely-targeted Metabolomics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Widely-targeted Metabolomics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Plant Widely-targeted Metabolomics
- Animal Widely-targeted Metabolomics
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Creative Proteomics
- Lifeasible
- BGI Genomics
- Metware Biotechnology Inc (Metware)
- TianGen
- Gene Denovo
- SHANGHAI OE Biotech
- ShangHai Biotree
1. How big is the global Widely-targeted Metabolomics market?
2. What is the demand of the global Widely-targeted Metabolomics market?
3. What is the year over year growth of the global Widely-targeted Metabolomics market?
4. What is the total value of the global Widely-targeted Metabolomics market?
5. Who are the Major Players in the global Widely-targeted Metabolomics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Widely-targeted Metabolomics Introduction
1.2 World Widely-targeted Metabolomics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Widely-targeted Metabolomics Total Market by Region (by Headquarter Location)
1.3.1 World Widely-targeted Metabolomics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.3 China Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.4 Europe Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.5 Japan Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.6 South Korea Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.7 ASEAN Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.8 India Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Widely-targeted Metabolomics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Widely-targeted Metabolomics Consumption Value (2021-2032)
2.2 World Widely-targeted Metabolomics Consumption Value by Region
2.2.1 World Widely-targeted Metabolomics Consumption Value by Region (2021-2026)
2.2.2 World Widely-targeted Metabolomics Consumption Value Forecast by Region (2027-2032)
2.3 United States Widely-targeted Metabolomics Consumption Value (2021-2032)
2.4 China Widely-targeted Metabolomics Consumption Value (2021-2032)
2.5 Europe Widely-targeted Metabolomics Consumption Value (2021-2032)
2.6 Japan Widely-targeted Metabolomics Consumption Value (2021-2032)
2.7 South Korea Widely-targeted Metabolomics Consumption Value (2021-2032)
2.8 ASEAN Widely-targeted Metabolomics Consumption Value (2021-2032)
2.9 India Widely-targeted Metabolomics Consumption Value (2021-2032)
3 WORLD WIDELY-TARGETED METABOLOMICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Widely-targeted Metabolomics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Widely-targeted Metabolomics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Widely-targeted Metabolomics in 2025
3.2.3 Global Concentration Ratios (CR8) for Widely-targeted Metabolomics in 2025
3.3 Widely-targeted Metabolomics Company Evaluation Quadrant
3.4 Widely-targeted Metabolomics Market: Overall Company Footprint Analysis
3.4.1 Widely-targeted Metabolomics Market: Region Footprint
3.4.2 Widely-targeted Metabolomics Market: Company Product Type Footprint
3.4.3 Widely-targeted Metabolomics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Widely-targeted Metabolomics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Widely-targeted Metabolomics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Widely-targeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Widely-targeted Metabolomics Consumption Value Comparison
4.2.1 United States VS China: Widely-targeted Metabolomics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Widely-targeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Widely-targeted Metabolomics Companies and Market Share, 2021-2026
4.3.1 United States Based Widely-targeted Metabolomics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Widely-targeted Metabolomics Revenue, (2021-2026)
4.4 China Based Companies Widely-targeted Metabolomics Revenue and Market Share, 2021-2026
4.4.1 China Based Widely-targeted Metabolomics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Widely-targeted Metabolomics Revenue, (2021-2026)
4.5 Rest of World Based Widely-targeted Metabolomics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Widely-targeted Metabolomics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Widely-targeted Metabolomics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Widely-targeted Metabolomics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plant Widely-targeted Metabolomics
5.2.2 Animal Widely-targeted Metabolomics
5.3 Market Segment by Type
5.3.1 World Widely-targeted Metabolomics Market Size by Type (2021-2026)
5.3.2 World Widely-targeted Metabolomics Market Size by Type (2027-2032)
5.3.3 World Widely-targeted Metabolomics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Widely-targeted Metabolomics Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Academic and Research Institutions
6.2.2 Pharmaceutical and Biotechnology Companies
6.2.3 Contract Research Organizations
6.3 Market Segment by Application
6.3.1 World Widely-targeted Metabolomics Market Size by Application (2021-2026)
6.3.2 World Widely-targeted Metabolomics Market Size by Application (2027-2032)
6.3.3 World Widely-targeted Metabolomics Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Creative Proteomics
7.1.1 Creative Proteomics Details
7.1.2 Creative Proteomics Major Business
7.1.3 Creative Proteomics Widely-targeted Metabolomics Product and Services
7.1.4 Creative Proteomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Creative Proteomics Recent Developments/Updates
7.1.6 Creative Proteomics Competitive Strengths & Weaknesses
7.2 Lifeasible
7.2.1 Lifeasible Details
7.2.2 Lifeasible Major Business
7.2.3 Lifeasible Widely-targeted Metabolomics Product and Services
7.2.4 Lifeasible Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Lifeasible Recent Developments/Updates
7.2.6 Lifeasible Competitive Strengths & Weaknesses
7.3 BGI Genomics
7.3.1 BGI Genomics Details
7.3.2 BGI Genomics Major Business
7.3.3 BGI Genomics Widely-targeted Metabolomics Product and Services
7.3.4 BGI Genomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 BGI Genomics Recent Developments/Updates
7.3.6 BGI Genomics Competitive Strengths & Weaknesses
7.4 Metware Biotechnology Inc (Metware)
7.4.1 Metware Biotechnology Inc (Metware) Details
7.4.2 Metware Biotechnology Inc (Metware) Major Business
7.4.3 Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Product and Services
7.4.4 Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Metware Biotechnology Inc (Metware) Recent Developments/Updates
7.4.6 Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
7.5 TianGen
7.5.1 TianGen Details
7.5.2 TianGen Major Business
7.5.3 TianGen Widely-targeted Metabolomics Product and Services
7.5.4 TianGen Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 TianGen Recent Developments/Updates
7.5.6 TianGen Competitive Strengths & Weaknesses
7.6 Gene Denovo
7.6.1 Gene Denovo Details
7.6.2 Gene Denovo Major Business
7.6.3 Gene Denovo Widely-targeted Metabolomics Product and Services
7.6.4 Gene Denovo Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Gene Denovo Recent Developments/Updates
7.6.6 Gene Denovo Competitive Strengths & Weaknesses
7.7 SHANGHAI OE Biotech
7.7.1 SHANGHAI OE Biotech Details
7.7.2 SHANGHAI OE Biotech Major Business
7.7.3 SHANGHAI OE Biotech Widely-targeted Metabolomics Product and Services
7.7.4 SHANGHAI OE Biotech Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 SHANGHAI OE Biotech Recent Developments/Updates
7.7.6 SHANGHAI OE Biotech Competitive Strengths & Weaknesses
7.8 ShangHai Biotree
7.8.1 ShangHai Biotree Details
7.8.2 ShangHai Biotree Major Business
7.8.3 ShangHai Biotree Widely-targeted Metabolomics Product and Services
7.8.4 ShangHai Biotree Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 ShangHai Biotree Recent Developments/Updates
7.8.6 ShangHai Biotree Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Widely-targeted Metabolomics Industry Chain
8.2 Widely-targeted Metabolomics Upstream Analysis
8.3 Widely-targeted Metabolomics Midstream Analysis
8.4 Widely-targeted Metabolomics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Widely-targeted Metabolomics Introduction
1.2 World Widely-targeted Metabolomics Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Widely-targeted Metabolomics Total Market by Region (by Headquarter Location)
1.3.1 World Widely-targeted Metabolomics Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.3 China Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.4 Europe Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.5 Japan Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.6 South Korea Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.7 ASEAN Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.3.8 India Based Company Widely-targeted Metabolomics Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Widely-targeted Metabolomics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Widely-targeted Metabolomics Consumption Value (2021-2032)
2.2 World Widely-targeted Metabolomics Consumption Value by Region
2.2.1 World Widely-targeted Metabolomics Consumption Value by Region (2021-2026)
2.2.2 World Widely-targeted Metabolomics Consumption Value Forecast by Region (2027-2032)
2.3 United States Widely-targeted Metabolomics Consumption Value (2021-2032)
2.4 China Widely-targeted Metabolomics Consumption Value (2021-2032)
2.5 Europe Widely-targeted Metabolomics Consumption Value (2021-2032)
2.6 Japan Widely-targeted Metabolomics Consumption Value (2021-2032)
2.7 South Korea Widely-targeted Metabolomics Consumption Value (2021-2032)
2.8 ASEAN Widely-targeted Metabolomics Consumption Value (2021-2032)
2.9 India Widely-targeted Metabolomics Consumption Value (2021-2032)
3 WORLD WIDELY-TARGETED METABOLOMICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Widely-targeted Metabolomics Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Widely-targeted Metabolomics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Widely-targeted Metabolomics in 2025
3.2.3 Global Concentration Ratios (CR8) for Widely-targeted Metabolomics in 2025
3.3 Widely-targeted Metabolomics Company Evaluation Quadrant
3.4 Widely-targeted Metabolomics Market: Overall Company Footprint Analysis
3.4.1 Widely-targeted Metabolomics Market: Region Footprint
3.4.2 Widely-targeted Metabolomics Market: Company Product Type Footprint
3.4.3 Widely-targeted Metabolomics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Widely-targeted Metabolomics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Widely-targeted Metabolomics Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Widely-targeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Widely-targeted Metabolomics Consumption Value Comparison
4.2.1 United States VS China: Widely-targeted Metabolomics Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Widely-targeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Widely-targeted Metabolomics Companies and Market Share, 2021-2026
4.3.1 United States Based Widely-targeted Metabolomics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Widely-targeted Metabolomics Revenue, (2021-2026)
4.4 China Based Companies Widely-targeted Metabolomics Revenue and Market Share, 2021-2026
4.4.1 China Based Widely-targeted Metabolomics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Widely-targeted Metabolomics Revenue, (2021-2026)
4.5 Rest of World Based Widely-targeted Metabolomics Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Widely-targeted Metabolomics Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Widely-targeted Metabolomics Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Widely-targeted Metabolomics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Plant Widely-targeted Metabolomics
5.2.2 Animal Widely-targeted Metabolomics
5.3 Market Segment by Type
5.3.1 World Widely-targeted Metabolomics Market Size by Type (2021-2026)
5.3.2 World Widely-targeted Metabolomics Market Size by Type (2027-2032)
5.3.3 World Widely-targeted Metabolomics Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Widely-targeted Metabolomics Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Academic and Research Institutions
6.2.2 Pharmaceutical and Biotechnology Companies
6.2.3 Contract Research Organizations
6.3 Market Segment by Application
6.3.1 World Widely-targeted Metabolomics Market Size by Application (2021-2026)
6.3.2 World Widely-targeted Metabolomics Market Size by Application (2027-2032)
6.3.3 World Widely-targeted Metabolomics Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Creative Proteomics
7.1.1 Creative Proteomics Details
7.1.2 Creative Proteomics Major Business
7.1.3 Creative Proteomics Widely-targeted Metabolomics Product and Services
7.1.4 Creative Proteomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Creative Proteomics Recent Developments/Updates
7.1.6 Creative Proteomics Competitive Strengths & Weaknesses
7.2 Lifeasible
7.2.1 Lifeasible Details
7.2.2 Lifeasible Major Business
7.2.3 Lifeasible Widely-targeted Metabolomics Product and Services
7.2.4 Lifeasible Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Lifeasible Recent Developments/Updates
7.2.6 Lifeasible Competitive Strengths & Weaknesses
7.3 BGI Genomics
7.3.1 BGI Genomics Details
7.3.2 BGI Genomics Major Business
7.3.3 BGI Genomics Widely-targeted Metabolomics Product and Services
7.3.4 BGI Genomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 BGI Genomics Recent Developments/Updates
7.3.6 BGI Genomics Competitive Strengths & Weaknesses
7.4 Metware Biotechnology Inc (Metware)
7.4.1 Metware Biotechnology Inc (Metware) Details
7.4.2 Metware Biotechnology Inc (Metware) Major Business
7.4.3 Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Product and Services
7.4.4 Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Metware Biotechnology Inc (Metware) Recent Developments/Updates
7.4.6 Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
7.5 TianGen
7.5.1 TianGen Details
7.5.2 TianGen Major Business
7.5.3 TianGen Widely-targeted Metabolomics Product and Services
7.5.4 TianGen Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 TianGen Recent Developments/Updates
7.5.6 TianGen Competitive Strengths & Weaknesses
7.6 Gene Denovo
7.6.1 Gene Denovo Details
7.6.2 Gene Denovo Major Business
7.6.3 Gene Denovo Widely-targeted Metabolomics Product and Services
7.6.4 Gene Denovo Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Gene Denovo Recent Developments/Updates
7.6.6 Gene Denovo Competitive Strengths & Weaknesses
7.7 SHANGHAI OE Biotech
7.7.1 SHANGHAI OE Biotech Details
7.7.2 SHANGHAI OE Biotech Major Business
7.7.3 SHANGHAI OE Biotech Widely-targeted Metabolomics Product and Services
7.7.4 SHANGHAI OE Biotech Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 SHANGHAI OE Biotech Recent Developments/Updates
7.7.6 SHANGHAI OE Biotech Competitive Strengths & Weaknesses
7.8 ShangHai Biotree
7.8.1 ShangHai Biotree Details
7.8.2 ShangHai Biotree Major Business
7.8.3 ShangHai Biotree Widely-targeted Metabolomics Product and Services
7.8.4 ShangHai Biotree Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 ShangHai Biotree Recent Developments/Updates
7.8.6 ShangHai Biotree Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Widely-targeted Metabolomics Industry Chain
8.2 Widely-targeted Metabolomics Upstream Analysis
8.3 Widely-targeted Metabolomics Midstream Analysis
8.4 Widely-targeted Metabolomics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Widely-targeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Widely-targeted Metabolomics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Widely-targeted Metabolomics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Widely-targeted Metabolomics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Widely-targeted Metabolomics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Widely-targeted Metabolomics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Widely-targeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Widely-targeted Metabolomics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Widely-targeted Metabolomics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Widely-targeted Metabolomics Players in 2025
Table 12. World Widely-targeted Metabolomics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Widely-targeted Metabolomics Company Evaluation Quadrant
Table 14. Head Office of Key Widely-targeted Metabolomics Players
Table 15. Widely-targeted Metabolomics Market: Company Product Type Footprint
Table 16. Widely-targeted Metabolomics Market: Company Product Application Footprint
Table 17. Widely-targeted Metabolomics Mergers & Acquisitions Activity
Table 18. United States VS China Widely-targeted Metabolomics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Widely-targeted Metabolomics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Widely-targeted Metabolomics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Widely-targeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Widely-targeted Metabolomics Revenue Market Share (2021-2026)
Table 23. China Based Widely-targeted Metabolomics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Widely-targeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Widely-targeted Metabolomics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Widely-targeted Metabolomics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Widely-targeted Metabolomics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Widely-targeted Metabolomics Revenue Market Share (2021-2026)
Table 29. World Widely-targeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Widely-targeted Metabolomics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Widely-targeted Metabolomics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Widely-targeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Widely-targeted Metabolomics Market Size by Application (2021-2026) & (USD Million)
Table 34. World Widely-targeted Metabolomics Market Size by Application (2027-2032) & (USD Million)
Table 35. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 36. Creative Proteomics Major Business
Table 37. Creative Proteomics Widely-targeted Metabolomics Product and Services
Table 38. Creative Proteomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Creative Proteomics Recent Developments/Updates
Table 40. Creative Proteomics Competitive Strengths & Weaknesses
Table 41. Lifeasible Basic Information, Manufacturing Base and Competitors
Table 42. Lifeasible Major Business
Table 43. Lifeasible Widely-targeted Metabolomics Product and Services
Table 44. Lifeasible Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lifeasible Recent Developments/Updates
Table 46. Lifeasible Competitive Strengths & Weaknesses
Table 47. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 48. BGI Genomics Major Business
Table 49. BGI Genomics Widely-targeted Metabolomics Product and Services
Table 50. BGI Genomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BGI Genomics Recent Developments/Updates
Table 52. BGI Genomics Competitive Strengths & Weaknesses
Table 53. Metware Biotechnology Inc (Metware) Basic Information, Manufacturing Base and Competitors
Table 54. Metware Biotechnology Inc (Metware) Major Business
Table 55. Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Product and Services
Table 56. Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Metware Biotechnology Inc (Metware) Recent Developments/Updates
Table 58. Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
Table 59. TianGen Basic Information, Manufacturing Base and Competitors
Table 60. TianGen Major Business
Table 61. TianGen Widely-targeted Metabolomics Product and Services
Table 62. TianGen Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. TianGen Recent Developments/Updates
Table 64. TianGen Competitive Strengths & Weaknesses
Table 65. Gene Denovo Basic Information, Manufacturing Base and Competitors
Table 66. Gene Denovo Major Business
Table 67. Gene Denovo Widely-targeted Metabolomics Product and Services
Table 68. Gene Denovo Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Gene Denovo Recent Developments/Updates
Table 70. Gene Denovo Competitive Strengths & Weaknesses
Table 71. SHANGHAI OE Biotech Basic Information, Manufacturing Base and Competitors
Table 72. SHANGHAI OE Biotech Major Business
Table 73. SHANGHAI OE Biotech Widely-targeted Metabolomics Product and Services
Table 74. SHANGHAI OE Biotech Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SHANGHAI OE Biotech Recent Developments/Updates
Table 76. SHANGHAI OE Biotech Competitive Strengths & Weaknesses
Table 77. ShangHai Biotree Basic Information, Manufacturing Base and Competitors
Table 78. ShangHai Biotree Major Business
Table 79. ShangHai Biotree Widely-targeted Metabolomics Product and Services
Table 80. ShangHai Biotree Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ShangHai Biotree Recent Developments/Updates
Table 82. ShangHai Biotree Competitive Strengths & Weaknesses
Table 83. Global Key Players of Widely-targeted Metabolomics Upstream (Raw Materials)
Table 84. Global Widely-targeted Metabolomics Typical Customers
Table 1. World Widely-targeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Widely-targeted Metabolomics Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Widely-targeted Metabolomics Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Widely-targeted Metabolomics Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Widely-targeted Metabolomics Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Widely-targeted Metabolomics Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Widely-targeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Widely-targeted Metabolomics Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Widely-targeted Metabolomics Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Widely-targeted Metabolomics Players in 2025
Table 12. World Widely-targeted Metabolomics Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Widely-targeted Metabolomics Company Evaluation Quadrant
Table 14. Head Office of Key Widely-targeted Metabolomics Players
Table 15. Widely-targeted Metabolomics Market: Company Product Type Footprint
Table 16. Widely-targeted Metabolomics Market: Company Product Application Footprint
Table 17. Widely-targeted Metabolomics Mergers & Acquisitions Activity
Table 18. United States VS China Widely-targeted Metabolomics Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Widely-targeted Metabolomics Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Widely-targeted Metabolomics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Widely-targeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Widely-targeted Metabolomics Revenue Market Share (2021-2026)
Table 23. China Based Widely-targeted Metabolomics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Widely-targeted Metabolomics Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Widely-targeted Metabolomics Revenue Market Share (2021-2026)
Table 26. Rest of World Based Widely-targeted Metabolomics Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Widely-targeted Metabolomics Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Widely-targeted Metabolomics Revenue Market Share (2021-2026)
Table 29. World Widely-targeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Widely-targeted Metabolomics Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Widely-targeted Metabolomics Market Size by Type (2027-2032) & (USD Million)
Table 32. World Widely-targeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Widely-targeted Metabolomics Market Size by Application (2021-2026) & (USD Million)
Table 34. World Widely-targeted Metabolomics Market Size by Application (2027-2032) & (USD Million)
Table 35. Creative Proteomics Basic Information, Manufacturing Base and Competitors
Table 36. Creative Proteomics Major Business
Table 37. Creative Proteomics Widely-targeted Metabolomics Product and Services
Table 38. Creative Proteomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Creative Proteomics Recent Developments/Updates
Table 40. Creative Proteomics Competitive Strengths & Weaknesses
Table 41. Lifeasible Basic Information, Manufacturing Base and Competitors
Table 42. Lifeasible Major Business
Table 43. Lifeasible Widely-targeted Metabolomics Product and Services
Table 44. Lifeasible Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Lifeasible Recent Developments/Updates
Table 46. Lifeasible Competitive Strengths & Weaknesses
Table 47. BGI Genomics Basic Information, Manufacturing Base and Competitors
Table 48. BGI Genomics Major Business
Table 49. BGI Genomics Widely-targeted Metabolomics Product and Services
Table 50. BGI Genomics Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. BGI Genomics Recent Developments/Updates
Table 52. BGI Genomics Competitive Strengths & Weaknesses
Table 53. Metware Biotechnology Inc (Metware) Basic Information, Manufacturing Base and Competitors
Table 54. Metware Biotechnology Inc (Metware) Major Business
Table 55. Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Product and Services
Table 56. Metware Biotechnology Inc (Metware) Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Metware Biotechnology Inc (Metware) Recent Developments/Updates
Table 58. Metware Biotechnology Inc (Metware) Competitive Strengths & Weaknesses
Table 59. TianGen Basic Information, Manufacturing Base and Competitors
Table 60. TianGen Major Business
Table 61. TianGen Widely-targeted Metabolomics Product and Services
Table 62. TianGen Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. TianGen Recent Developments/Updates
Table 64. TianGen Competitive Strengths & Weaknesses
Table 65. Gene Denovo Basic Information, Manufacturing Base and Competitors
Table 66. Gene Denovo Major Business
Table 67. Gene Denovo Widely-targeted Metabolomics Product and Services
Table 68. Gene Denovo Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Gene Denovo Recent Developments/Updates
Table 70. Gene Denovo Competitive Strengths & Weaknesses
Table 71. SHANGHAI OE Biotech Basic Information, Manufacturing Base and Competitors
Table 72. SHANGHAI OE Biotech Major Business
Table 73. SHANGHAI OE Biotech Widely-targeted Metabolomics Product and Services
Table 74. SHANGHAI OE Biotech Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SHANGHAI OE Biotech Recent Developments/Updates
Table 76. SHANGHAI OE Biotech Competitive Strengths & Weaknesses
Table 77. ShangHai Biotree Basic Information, Manufacturing Base and Competitors
Table 78. ShangHai Biotree Major Business
Table 79. ShangHai Biotree Widely-targeted Metabolomics Product and Services
Table 80. ShangHai Biotree Widely-targeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ShangHai Biotree Recent Developments/Updates
Table 82. ShangHai Biotree Competitive Strengths & Weaknesses
Table 83. Global Key Players of Widely-targeted Metabolomics Upstream (Raw Materials)
Table 84. Global Widely-targeted Metabolomics Typical Customers
LIST OF FIGURES
Figure 1. Widely-targeted Metabolomics Picture
Figure 2. World Widely-targeted Metabolomics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Widely-targeted Metabolomics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Widely-targeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Widely-targeted Metabolomics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 13. Widely-targeted Metabolomics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Widely-targeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Widely-targeted Metabolomics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Widely-targeted Metabolomics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Widely-targeted Metabolomics Markets in 2025
Figure 27. United States VS China: Widely-targeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Widely-targeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Widely-targeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Widely-targeted Metabolomics Market Size Market Share by Type in 2025
Figure 31. Plant Widely-targeted Metabolomics
Figure 32. Animal Widely-targeted Metabolomics
Figure 33. World Widely-targeted Metabolomics Market Size Market Share by Type (2021-2032)
Figure 34. World Widely-targeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Widely-targeted Metabolomics Market Size Market Share by Application in 2025
Figure 36. Academic and Research Institutions
Figure 37. Pharmaceutical and Biotechnology Companies
Figure 38. Contract Research Organizations
Figure 39. World Widely-targeted Metabolomics Market Size Market Share by Application (2021-2032)
Figure 40. Widely-targeted Metabolomics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Widely-targeted Metabolomics Picture
Figure 2. World Widely-targeted Metabolomics Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Widely-targeted Metabolomics Total Revenue (2021-2032) & (USD Million)
Figure 4. World Widely-targeted Metabolomics Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Widely-targeted Metabolomics Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Widely-targeted Metabolomics Revenue (2021-2032) & (USD Million)
Figure 13. Widely-targeted Metabolomics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 16. World Widely-targeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 18. China Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 23. India Widely-targeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Widely-targeted Metabolomics by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Widely-targeted Metabolomics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Widely-targeted Metabolomics Markets in 2025
Figure 27. United States VS China: Widely-targeted Metabolomics Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Widely-targeted Metabolomics Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Widely-targeted Metabolomics Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Widely-targeted Metabolomics Market Size Market Share by Type in 2025
Figure 31. Plant Widely-targeted Metabolomics
Figure 32. Animal Widely-targeted Metabolomics
Figure 33. World Widely-targeted Metabolomics Market Size Market Share by Type (2021-2032)
Figure 34. World Widely-targeted Metabolomics Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. World Widely-targeted Metabolomics Market Size Market Share by Application in 2025
Figure 36. Academic and Research Institutions
Figure 37. Pharmaceutical and Biotechnology Companies
Figure 38. Contract Research Organizations
Figure 39. World Widely-targeted Metabolomics Market Size Market Share by Application (2021-2032)
Figure 40. Widely-targeted Metabolomics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
